Shares of hVIVO plc (LON:HVO – Get Free Report) dropped 6.8% during mid-day trading on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,268,262 shares were traded during trading, a decline of 33% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Price Performance
The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company’s fifty day moving average price is GBX 23.20 and its 200-day moving average price is GBX 26.66. The stock has a market capitalization of £129.95 million, a PE ratio of 636.67 and a beta of 0.97.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- What Do S&P 500 Stocks Tell Investors About the Market?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Stock Market Sectors: What Are They and How Many Are There?
- Nebius Group: The Rising Star in AI Infrastructure
- What is the Australian Securities Exchange (ASX)
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
